Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
STAND+
AddedFeb 15, 2024
UpdatedJul 3, 2026
STAND+

STAND+

Series A

GALES: Innovating healthcare with smart, stylish, and easy-to-clean PPE footwear for medical professionals.

HQ
Malibu, CA, US
Founded
2020
Accelerator
Techstars logoTechstars: Boulder2021
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to innovate healthcare, Gales focuses on providing smart, stylish, and easy-to-clean PPE footwear specifically designed for medical professionals. Their core product line includes shoes that are slip-resistant, shock-absorbent, fluid-resistant, antimicrobial, and eligible for HSA/FSA. Gales aims to improve the lives of healthcare workers by offering footwear that combines comfort and functionality, addressing the unique demands of frontline defense nurses, medical workers, and other healthcare professionals.

Gales has garnered attention for its impactful contributions to healthcare innovation. The company has partnered with various healthcare organizations to distribute its products widely. Notable investors and affiliated individuals include leaders in the healthcare and tech industries who support Gales' vision of enhancing the daily lives of medical professionals. The company's achievements include widespread adoption of their footwear in hospitals and clinics, contributing to better working conditions for healthcare workers.

STAND+ - Similar Companies

Clove logo

Clove

goclove.com

Kizik logo

Kizik

kizik.com

Xena Workwear logo

Xena Workwear

xenaworkwear.com

REZA logo

REZA

rezafootwear.com

Pashion Footwear logo

Pashion Footwear

IAMBIC logo

IAMBIC

iambic.co

Pandere Shoes logo

Pandere Shoes

pandereshoes.com

Aegle Gear logo

Aegle Gear

Islide logo

Islide

islideusa.com

Floafers logo

Floafers

floafers.com

Season Three logo

Season Three

seasonthree.com

Careismatic Brands logo

Careismatic Brands

careismatic.com

True Linkswear logo

True Linkswear

truelinkswear.com

Findmeashoe logo

Findmeashoe

findmeashoe.in

Forsake logo

Forsake

forsake.com

STAND+ - Quick Facts

Who are STAND+'s competitors?

Companies similar to STAND+ include Clove, Kizik, Xena Workwear and REZA.

When was STAND+ founded?

STAND+ was founded in 2020.

Where is STAND+'s headquarters located?

STAND+'s headquarters is located in Malibu, CA, US.

When was STAND+'s last funding round?

STAND+'s most recent funding round was for $2.6M (USD) in August 2022.

How much has STAND+ raised to-date?

As of Aug 22, 2022, STAND+ has raised a total of $4.7M (USD).

How many employees does STAND+ have?

STAND+ has 24 employees as of Feb 4, 2024.

STAND+ - Classification

Industry
  • Retail
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Footwear
  • PPE
Tags
  • eCommerce
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 10 more industry codes
NAICS
  • 310000Manufacturing
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 315000Apparel Manufacturing
  • 315200Cut and Sew Apparel Manufacturing
SIC
  • 8060Hospitals
  • 2300Apparel And Other Finished Products Made From Fabrics And Similar Material
  • 2380Miscellaneous Apparel And Accessories
  • 2389Apparel And Accessories, Not Elsewhere Classified